Raymond James & Associates Novartis Ag Transaction History

Raymond James & Associates

  • $150 Billion
  • Q2 2024

A detailed history of Raymond James & Associates transactions in Novartis Ag stock. As of the latest transaction made, Raymond James & Associates holds 536,607 shares of NVS stock, worth $62 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
536,607
Previous 529,840 1.28%
Holding current value
$62 Million
Previous $51.3 Million 11.47%
% of portfolio
0.04%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024
BUY
$92.57 - $107.37 $626,421 - $726,572
6,767 Added 1.28%
536,607 $57.1 Million
Q1 2024

Apr 22, 2024
BUY
$95.27 - $108.47 $1.09 Million - $1.24 Million
11,435 Added 2.21%
529,840 $51.3 Million
Q4 2023

Jan 16, 2024
BUY
$92.27 - $101.54 $2,122 - $2,335
23 Added 0.0%
518,405 $52.3 Million
Q3 2023

Oct 24, 2023
SELL
$94.73 - $105.13 $2.3 Million - $2.55 Million
-24,235 Reduced 4.47%
518,382 $52.8 Million
Q2 2023

Jul 25, 2023
SELL
$92.52 - $104.91 $918,168 - $1.04 Million
-9,924 Reduced 1.8%
542,617 $54.8 Million
Q1 2023

Apr 14, 2023
SELL
$80.03 - $92.81 $11.7 Million - $13.6 Million
-146,609 Reduced 20.97%
552,541 $50.8 Million
Q4 2022

Feb 08, 2023
SELL
$75.55 - $92.52 $6.42 Million - $7.86 Million
-84,968 Reduced 10.84%
699,150 $63.4 Million
Q3 2022

Oct 25, 2022
BUY
$74.61 - $87.26 $1.59 Million - $1.86 Million
21,322 Added 2.8%
784,118 $59.6 Million
Q2 2022

Aug 12, 2022
SELL
$80.52 - $93.75 $10.3 Million - $12 Million
-128,085 Reduced 14.38%
762,796 $64.5 Million
Q1 2022

May 11, 2022
BUY
$80.11 - $90.62 $4.09 Million - $4.62 Million
51,021 Added 6.07%
890,881 $78.2 Million
Q4 2021

Feb 08, 2022
BUY
$79.7 - $88.13 $917,107 - $1.01 Million
11,507 Added 1.39%
839,860 $73.5 Million
Q3 2021

Nov 02, 2021
SELL
$81.78 - $95.14 $9,404 - $10,941
-115 Reduced 0.01%
828,353 $67.7 Million
Q2 2021

Aug 11, 2021
SELL
$85.24 - $94.15 $8.04 Million - $8.88 Million
-94,313 Reduced 10.22%
828,468 $75.6 Million
Q1 2021

May 14, 2021
SELL
$83.5 - $98.47 $25.3 Million - $29.8 Million
-302,590 Reduced 24.69%
922,781 $78.9 Million
Q4 2020

Feb 12, 2021
BUY
$78.07 - $94.43 $5.1 Million - $6.16 Million
65,283 Added 5.63%
1,225,371 $116 Million
Q3 2020

Nov 04, 2020
SELL
$82.14 - $91.0 $9.99 Million - $11.1 Million
-121,681 Reduced 9.49%
1,160,088 $101 Million
Q2 2020

Jul 28, 2020
BUY
$80.93 - $91.1 $996,976 - $1.12 Million
12,319 Added 0.97%
1,281,769 $112 Million
Q1 2020

Apr 21, 2020
BUY
$70.67 - $99.01 $4.39 Million - $6.15 Million
62,098 Added 5.14%
1,269,450 $105 Million
Q4 2019

Feb 12, 2020
BUY
$84.35 - $95.37 $2.04 Million - $2.3 Million
24,154 Added 2.04%
1,207,352 $114 Million
Q3 2019

Nov 07, 2019
SELL
$85.54 - $94.26 $38.9 Million - $42.9 Million
-454,627 Reduced 27.76%
1,183,198 $103 Million
Q2 2019

Aug 06, 2019
BUY
$75.4 - $92.8 $6.2 Million - $7.63 Million
82,271 Added 5.29%
1,637,825 $150 Million
Q1 2019

May 06, 2019
BUY
$75.32 - $86.15 $3.1 Million - $3.54 Million
41,112 Added 2.71%
1,555,554 $150 Million
Q4 2018

Feb 11, 2019
BUY
$73.66 - $82.02 $3.09 Million - $3.45 Million
42,003 Added 2.85%
1,514,442 $130 Million
Q3 2018

Nov 14, 2018
BUY
$66.94 - $77.43 $26.4 Million - $30.5 Million
394,450 Added 36.59%
1,472,439 $127 Million
Q2 2018

Aug 14, 2018
SELL
$64.91 - $73.36 $4.31 Million - $4.87 Million
-66,357 Reduced 5.8%
1,077,989 $81.4 Million
Q1 2018

May 14, 2018
BUY
$70.39 - $84.15 $218,138 - $260,780
3,099 Added 0.27%
1,144,346 $92.5 Million
Q4 2017

Feb 14, 2018
BUY
$72.33 - $77.64 $3.8 Million - $4.07 Million
52,474 Added 4.82%
1,141,247 $95.8 Million
Q3 2017

Nov 13, 2017
SELL
$74.14 - $77.27 $2.1 Million - $2.19 Million
-28,279 Reduced 2.53%
1,088,773 $93.5 Million
Q2 2017

Aug 14, 2017
BUY
N/A
1,117,052
1,117,052 $93.2 Million

Others Institutions Holding NVS

# of Institutions
1,426
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email